Current Opinion in Lipidology

Papers
(The TQCC of Current Opinion in Lipidology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism58
Alveolar macrophages: guardians of the alveolar lipid galaxy58
Genetic variation in apolipoprotein A-V in hypertriglyceridemia57
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review56
Editorial introductions43
Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?39
ANGPTL4: a new mode in the regulation of intravascular lipolysis36
Sphingomyelins and ceramides: possible biomarkers for dementia?35
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease33
Implementation science and genetic testing for familial hypercholesterolemia32
The lipid-heart hypothesis from the Seven Countries Study of Cardiovascular Diseases31
Lipoprotein(a) and peripheral artery disease: contemporary evidence and therapeutic advances30
Oxidized LDL receptors: a recent update29
Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families?29
Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-1928
Exosomes and lipid metabolism in metabolic and cardiovascular disorders25
Lipid metabolism during pregnancy: consequences for mother and child22
Familial hypercholesterolemia in children and the importance of early treatment21
Editorial introductions19
Nonalcoholic fatty liver disease: an update18
Familial hypercholesterolemia in pregnancy17
Genetic determinants of pancreatitis risk in hypertriglyceridemia17
The current state of apolipoprotein E in dyslipidemia16
A new SPRING in lipid metabolism16
Inhibition of angiopoietin-like 3 for the management of severe hypercholesterolemia15
Splice correction therapies for familial hypercholesterolemic patients with low-density lipoprotein receptor mutations15
Nutrition and its impact on cardiovascular disease14
From clinical development to real-world outcomes with inclisiran14
APOE and familial hypercholesterolemia14
The need for national and international registries of patients with elevated lipoprotein(a)14
High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives14
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?14
Are the lipid-lowering effects of incretin-based therapies relevant for cardiovascular benefit?13
Beyond cholesterol: linking the conformation of apolipoprotein B to atherogenesis13
Can small dense LDL cholesterol be estimated from the lipid profile?13
Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent13
The intracellular chylomicron highway: novel insights into chylomicron biosynthesis, trafficking, and secretion13
Cardiomyocytes, sphingolipids and cardio myotoxicity12
Distinct roles of size-defined HDL subpopulations in cardiovascular disease12
The emerging role of fat-inducing transcript 2 in endoplasmic reticulum proteostasis and lipoprotein biogenesis12
Newborn screening for lipid disorders12
Editorial introductions11
The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease11
Pregnancy, cardiovascular health, and microchimerism10
Genetic testing for familial hypercholesterolemia10
Altered cardiovascular risk pattern of LDL cholesterol in older adults10
Recent dynamic studies of the metabolism of atherogenic lipoproteins: elucidating the mode of action of new therapies10
Clinical associations between exercise and lipoproteins9
Association of dietary patterns and components with atherosclerosis risk biomarkers in familial hypercholesterolemia9
Circulating protein and lipid markers of early sepsis diagnosis and prognosis: a scoping review9
Strategies for management of patients with elevated lipoprotein(a)9
Preprint servers in lipidology: current status and future role9
Genotype–phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia8
The pathophysiology of excess plasma-free cholesterol8
Prevention of cardiometabolic diseases through dietary modifications8
Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment8
0.12475609779358